Skip to main content
. Author manuscript; available in PMC: 2023 Jan 1.
Published in final edited form as: Adv Drug Deliv Rev. 2021 Nov 9;180:114042. doi: 10.1016/j.addr.2021.114042

Fig. 2.

Fig. 2.

Pooled CRISPR-Cas9 screens can identify functional RBPs in tumor progression. (A) Schematic of in vitro genetic screening with genome-wide lentiviral sgRNA libraries (Reprint from Koike-Yusa et al. [93]). (B) Schematic of in vivo genetic screening with genome-wide lentiviral sgRNA libraries to assess sgRNA representation (Reprint from Bieging-Rolett et al. [96]).